繁體
简体中文
繁體中文

Market Vectors Colombia ETF COLX

等待開盤 10-07 09:30:00 美东时间

0.00

0.000

NaN.00%

华盛通華盛通
立即下載
  • 最 高--
  • 今 開--
  • 成交量 0股
  • 最 低 --
  • 昨 收 0.00
  • 總市值 0
  • 52周最高 0.00
  • 市盈率 --
  • 換手率 NaN.00%
  • 52周最低 0.00
  • 委 比 0.00%
  • 總股本 --
  • 歷史最高 0.00
  • 量 比 0
  • 振 幅 NaN.00%
  • 歷史最低 0.00
  • 每 手 1
  • 風險率

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

    Collegium Pharmaceutical, Inc. will present nine posters at PAINWeek 2025, highlighting real-world data from its pain portfolio, including BELBUCA and XTAMPZA ER. The posters aim to provide insights for healthcare professionals and reflect the company's commitment to responsible pain management. The session will take place on September 4, 2025, in Las Vegas.

    08-25 12:00

  • Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

    Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. A live conference call and webcast will be held at 8:00 a.m. ET. Investors can join via phone at (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference "Collegium Pharmaceutical Q2 2025 Earnings Call." The webcast will be available on the Company’s website at www.collegium...

    07-24 12:00

  • Collegium Announces $150 Million Share Repurchase Program

    Collegium Pharmaceutical, Inc. announced a new $150 million stock repurchase program through December 31, 2026, replacing a previous program that expired with $65 million remaining. The company has returned $222 million to shareholders since 2021 and currently has 32.1 million shares outstanding.

    07-07 12:00